ロード中...
CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy
Artificial receptors designed for adoptive immune therapies need to absolve dual functions: antigen recognition and abilities to trigger the lytic machinery of reprogrammed effector T lymphocytes. In this way, CAR-T cells deliver their cytotoxic hit to cancer cells expressing targeted tumor antigens...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6514830/ https://ncbi.nlm.nih.gov/pubmed/30999624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20081903 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|